Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Waters (WAT – Research Report), Pharvaris ...

Canaccord Genuity Group currently has a buy rating on the medical device company’s stock. A number of other equities research ...

On Friday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $30.6 which represents a decrease of $-2.72 or -8.16% from the prior close of $33.32. The stock opened at $33.71 and ...

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) were down 9.6% on Friday after Canaccord Genuity Group lowered their price target on the stock from $57.00 to $56.00. Canaccord ...

Bernstein has recently initiated Tandem Diabetes Care Inc (TNDM) stock to Outperform rating, as announced on Today, according to Finviz. Earlier, on October 4, 2024, Goldman had initiated the stock to ...

Tandem Diabetes Care Inc (TNDM) achieves highest quarterly sales in history, driven by strong US and international growth, ...

Fintel reports that on November 6, 2024, Bernstein initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a ...

While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key ...

Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of 16.28% and 9.24%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...